Furthermore, it remains to be seen whether inhibition of the activation of the NLRP3 inflammasome, as recently shown with mesenchymal stem cells in murine and human lupus, has a more favourable efficacy/side-effect profile.50 Here, NLRP3 is linked to systemic lupus erythematosus.